2068 Hawthorne Street
To date, research on the human microbiome has produced few therapies. With large investments recently made in this space by pharmaceutical companies, it is merely a matter of time before practical microbiome therapeutics come to market, likely in a few years. Founded in 2010, Quorum Innovations, LLC is a specialty biopharmaceutical company developing and delivering innovative biotherapeutics to physicians and their patients. The human microbiome has the potential to transform our understanding of healthcare, and Quorum Innovations is poised to become a leader in this emerging field.
Founder and CEO: Nicholas T. Monsul
Founder and CSO: Eva A. Berkes
CBO: Dirk S. Henson
CMO: Jeffrey A. Darrey
Please click here for Quorum Innovations job opportunities.
Please click here for clinical trial information.